This aberrant metabolic state could be improved by modulating CPT1A in mesothelial cells, suggesting FAO enhancement in mesothelial cells is a potential treatment of peritoneal fibrosis. This evidence concerns the gene CPT1A and Peritoneal Fibrosis.